SARS-CoV-2 vaccine testing and trials in the pediatric population: biologic, ethical, research, and implementation challenges

Early on in the SARS-CoV-2 pandemic, the majority of infected children were either asymptomatic or had mild COVID-19 disease, prompting many to demand a higher acceptable risk threshold for pediatric vaccines. More recently, as children begin to make up a larger proportion of the infected population and following evidence of the mental and physical toll exacted by the pandemic on children, a pediatric vaccine is now more pressing. But challenges to widespread vaccine uptake remain. In this episode meet Dr. Chulie Ulloa from the University of California Irvine about a recent commentary she wrote with fellow pediatric providers, physician scientists and advocates for children about these challenges and how they might be overcome. 

Hosted on Acast. See acast.com/privacy for more information.

More from Pediatric Research Podcast

  1. 11:15What's hot in Endocrinology? Apr 24, 2024
  2. 13:18Conversation With Pediatric Researchers Cynthia Bearer and Eleanor MolloyMar 22, 2024
  3. 13:43Conversation with Linda de VriesFeb 06, 2024
  4. 13:46Global climate change: the defining issue of our time for our children’s healthJan 16, 2024
  5. 13:24Predicting functional and quality-of-life outcomes following pediatric sepsis.Nov 29, 2023
  6. 17:42Conversation with Dr. Maximo VentoNov 20, 2023
  7. 13:01The association of placental pathology and neurodevelopmental outcomes in patients with neonatal encephalopathyNov 02, 2023
  8. 11:59Do Bayley trajectories predict school-readiness better than single assessments in formerly very preterm infants?Oct 23, 2023
  9. 11:19Novel metrics to characterise the temporal lobe of very preterm infants.Sep 11, 2023
  10. 12:13Trends in fetal and neonatal outcomes during the COVID-19 pandemicAug 23, 2023